Moraxella Bovoculi Bacterin
Pinkeye protection.
Look to stop pinkeye before it starts. Boost immunity against Moraxella bovoculi with a new pinkeye vaccine now available from Merck Animal Health.
Pinkeye vaccines are a critical part of a three-step approach to managing pinkeye, including fly control and pasture management.
An Effective Approach at Preventing Pinkeye
M. bovis
The major cause of pinkeye is due to a bacteria called M. bovis. Vaccines such as Piliguard® Pinkeye-1, Piliguard® Pinkeye+7 and 20/20 Vision® 7 with SPUR™ from Merck Animal Health are available to help prevent against this pathogen.
M. bovoculi
In a recent study of 466 pinkeye cases, up to 80% of cases were found to include M. bovoculi alone, or along with M. bovis1.
It Takes Two
Utilizing a combination approach to vaccination against M. bovis and M. bovoculi helps your herd gain the maximum protection they need against pinkeye.
KEY BENEFITS
- Protects against 8 strains of M. bovoculi in one convenient shot1
- Proven safety2
- Available on the OneMerck program
- Support from Merck Animal Health team
- Replaces autogenous products
M. bovoculi bacterin vaccine is a conditionally licensed product. To purchase, please talk to your vet or contact your Merck Animal Health sales representative.
Research
Pinkeye Product Fact Sheet
Learn more about the complete line of pinkeye protection.
Winter Pinkeye
Pinkeye isn’t just a summer concern. Help producers prevent and treat pinkeye year-round.
New Findings with Bovine Pinkeye
Organisms such as Moraxella bovoculi appear to work as a co-pathogen.
No items to show.
For more cattle-friendly options, see the rest of the Merck Animal Health vaccine lineup.
1 Addison, B. June 2018. Progressive Dairy. New Findings with Bovine Pinkeye. https://www.progressivedairy.com/topics/herd-health/new-findings-with-bovinepinkeye.Accessed Feb 3, 2020.
2 USDA Summary of Studies Supporting USDA Product Licensure , January 12, 2017.